New Regulatory Requirements Tied to Drop in Intravitreal Bevacizumab UseNew Regulatory Requirements Tied to Drop in Intravitreal Bevacizumab Use

Regulations requiring patient-specific prescriptions (PSPs) for drugs used off-label may have caused a drop in prescriptions for intravitreal bevacizumab, with retinal specialists switching to medications that don't require PSPs, according to a study from Ohio. Reuters Health Information

Source: Medscape Ophthalmology Headlines - November 30, 2015 Category: Opthalmology Tags: Ophthalmology News Source Type: news